🟢 Aspire BioPharma is trading 5% up in pre-market with broader biotech strength a possible factor

Aspire BioPharma is trading 5% higher at $8.61, with broader biotech strength the most plausible context, though the connection is unconfirmed.

• It closed at $8.20 on September 22, 2026.
• No credible company-specific announcement, filing, earnings release, or other catalyst dated September 22 was identified.
• Search results show available September 22 filing records, but none was clearly linked to the move.